363 related articles for article (PubMed ID: 31387311)
1. Alzheimer's Disease Research Using Human Microglia.
Lue LF; Beach TG; Walker DG
Cells; 2019 Aug; 8(8):. PubMed ID: 31387311
[TBL] [Abstract][Full Text] [Related]
2. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
3. Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.
Quiroga IY; Cruikshank AE; Bond ML; Reed KSM; Evangelista BA; Tseng JH; Ragusa JV; Meeker RB; Won H; Cohen S; Cohen TJ; Phanstiel DH
J Neuroinflammation; 2022 Apr; 19(1):99. PubMed ID: 35459147
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
Thawkar BS; Kaur G
J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia.
Haenseler W; Rajendran L
Stem Cells; 2019 Jun; 37(6):724-730. PubMed ID: 30801863
[TBL] [Abstract][Full Text] [Related]
6. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
7. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease.
Islam R; Choudhary H; Rajan R; Vrionis F; Hanafy KA
J Cell Physiol; 2024 Jun; 239(6):e30829. PubMed ID: 35822939
[TBL] [Abstract][Full Text] [Related]
8. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
9. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore.
Gussago C; Casati M; Ferri E; Arosio B
J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915
[TBL] [Abstract][Full Text] [Related]
10. PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.
Rustenhoven J; Smith AM; Smyth LC; Jansson D; Scotter EL; Swanson MEV; Aalderink M; Coppieters N; Narayan P; Handley R; Overall C; Park TIH; Schweder P; Heppner P; Curtis MA; Faull RLM; Dragunow M
Mol Neurodegener; 2018 Aug; 13(1):44. PubMed ID: 30124174
[TBL] [Abstract][Full Text] [Related]
11. Microglia actions in Alzheimer’s disease.
Prokop S; Miller KR; Heppner FL
Acta Neuropathol; 2013 Oct; 126(4):461-77. PubMed ID: 24224195
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
[TBL] [Abstract][Full Text] [Related]
13. Development of a Chimeric Model to Study and Manipulate Human Microglia In Vivo.
Hasselmann J; Coburn MA; England W; Figueroa Velez DX; Kiani Shabestari S; Tu CH; McQuade A; Kolahdouzan M; Echeverria K; Claes C; Nakayama T; Azevedo R; Coufal NG; Han CZ; Cummings BJ; Davtyan H; Glass CK; Healy LM; Gandhi SP; Spitale RC; Blurton-Jones M
Neuron; 2019 Sep; 103(6):1016-1033.e10. PubMed ID: 31375314
[TBL] [Abstract][Full Text] [Related]
14. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
15. The Role of TREML2 in Alzheimer's Disease.
Wang SY; Gong PY; E Y; Zhang YD; Jiang T
J Alzheimers Dis; 2020; 76(3):799-806. PubMed ID: 32568208
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
Spangenberg EE; Green KN
Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
[TBL] [Abstract][Full Text] [Related]
17. Microglial activation in Alzheimer's disease.
Schlachetzki JC; Hüll M
Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
[TBL] [Abstract][Full Text] [Related]
18. Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.
Rangaraju S; Gearing M; Jin LW; Levey A
J Alzheimers Dis; 2015; 44(3):797-808. PubMed ID: 25362031
[TBL] [Abstract][Full Text] [Related]
19. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
20. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
